Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 59

Cited In for PubMed (Select 9857976)

1.

Involvement of Serotonin Transporter Gene Polymorphisms (5-HTT) in Impulsive Behavior in the Japanese Population.

Nomura M, Kaneko M, Okuma Y, Nomura J, Kusumi I, Koyama T, Nomura Y.

PLoS One. 2015 Mar 16;10(3):e0119743. doi: 10.1371/journal.pone.0119743. eCollection 2015.

2.

Evaluation of the promoter region polymorphism (5-HTTLPR) in the serotonin transporter gene in females with postpartum depression.

Zhang X, Wang L, Huang F, Li J, Xiong L, Xue H, Zhang Y.

Exp Ther Med. 2015 Jan;9(1):245-249. Epub 2014 Oct 31.

3.

Genetic prediction of antidepressant drug response and nonresponse in Korean patients.

Lim SW, Won HH, Kim H, Myung W, Kim S, Kim KK, Carroll BJ, Kim JW, Kim DK.

PLoS One. 2014 Sep 16;9(9):e107098. doi: 10.1371/journal.pone.0107098. eCollection 2014.

4.

From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment.

Fabbri C, Porcelli S, Serretti A.

Can J Psychiatry. 2014 Feb;59(2):62-75. Review.

5.

The influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder.

Tomita T, Yasui-Furukori N, Nakagami T, Tsuchimine S, Ishioka M, Kaneda A, Sugawara N, Kaneko S.

PLoS One. 2014 May 23;9(5):e98099. doi: 10.1371/journal.pone.0098099. eCollection 2014.

6.

Serotonin Transporter Polymorphism (5-HTTLPR) and Citalopram Effectiveness in Iranian Patients with Major Depressive Disorder.

Sahraian S, Babashams M, Reza-Soltani P, Najmabadi H, Kahrizi K, Gorgani SH.

Iran J Psychiatry. 2013 Jun;8(2):86-91.

7.

Personalized medicine in psychiatry: problems and promises.

Ozomaro U, Wahlestedt C, Nemeroff CB.

BMC Med. 2013 May 16;11:132. doi: 10.1186/1741-7015-11-132. Review.

8.

Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.

Felger JC, Lotrich FE.

Neuroscience. 2013 Aug 29;246:199-229. doi: 10.1016/j.neuroscience.2013.04.060. Epub 2013 May 3. Review.

9.

Response to citalopram is not associated with SLC6A4 genotype in African-Americans and Caucasians with major depression.

Poland RE, Lesser IM, Wan YJ, Gertsik L, Yao J, Raffel LJ, Lin KM, Myers HF.

Life Sci. 2013 May 30;92(20-21):967-70. doi: 10.1016/j.lfs.2013.03.009. Epub 2013 Apr 3.

10.

Baseline thyroid indices and the subsequent response to citalopram treatment, a pilot study.

Abulseoud OA, Gitlin M, Altshuler L, Frye MA.

Brain Behav. 2013 Mar;3(2):89-94. doi: 10.1002/brb3.109. Epub 2013 Jan 18.

11.

Clinical and molecular genetics of psychotic depression.

Domschke K.

Schizophr Bull. 2013 Jul;39(4):766-75. doi: 10.1093/schbul/sbt040. Epub 2013 Mar 19. Review.

12.

RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis.

Ferrés-Coy A, Pilar-Cuellar F, Vidal R, Paz V, Masana M, Cortés R, Carmona MC, Campa L, Pazos A, Montefeltro A, Valdizán EM, Artigas F, Bortolozzi A.

Transl Psychiatry. 2013 Jan 15;3:e211. doi: 10.1038/tp.2012.135.

13.

Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy.

Kenna GA, Roder-Hanna N, Leggio L, Zywiak WH, Clifford J, Edwards S, Kenna JA, Shoaff J, Swift RM.

Pharmgenomics Pers Med. 2012;5:19-35. doi: 10.2147/PGPM.S23462. Epub 2012 Jan 13.

14.

Genome-wide approaches to antidepressant treatment: working towards understanding and predicting response.

Hodgson K, Mufti SJ, Uher R, McGuffin P.

Genome Med. 2012 Jun 27;4(6):52. doi: 10.1186/gm351.

15.

Neurogenetics of depression: a focus on reward processing and stress sensitivity.

Bogdan R, Nikolova YS, Pizzagalli DA.

Neurobiol Dis. 2013 Apr;52:12-23. doi: 10.1016/j.nbd.2012.05.007. Epub 2012 Jun 1. Review.

16.

5-HTTLPR polymorphism impacts task-evoked and resting-state activities of the amygdala in Han Chinese.

Li S, Zou Q, Li J, Li J, Wang D, Yan C, Dong Q, Zang YF.

PLoS One. 2012;7(5):e36513. doi: 10.1371/journal.pone.0036513. Epub 2012 May 4.

17.

Pathophysiologic findings of irritable bowel syndrome in china.

Zhong L, Hou X.

J Neurogastroenterol Motil. 2012 Jan;18(1):19-33. doi: 10.5056/jnm.2012.18.1.19. Epub 2012 Jan 16.

18.

The clinical pharmacology of depressive states.

Schulz P, Macher JP.

Dialogues Clin Neurosci. 2002 Mar;4(1):47-56.

19.

Indianizing psychiatry - Is there a case enough?

Avasthi A.

Indian J Psychiatry. 2011 Apr;53(2):111-20. doi: 10.4103/0019-5545.82534.

20.

Pharmacogenetics of antidepressants.

Crisafulli C, Fabbri C, Porcelli S, Drago A, Spina E, De Ronchi D, Serretti A.

Front Pharmacol. 2011 Feb 16;2:6. doi: 10.3389/fphar.2011.00006. eCollection 2011.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk